This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (68)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Colon Cancer  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

How Aggressive Should We Be?

Seth A. Rosen, MD; Joseph F. Buell, MD; Atsushi Yoshida, MD; Scott Kazsuba, BS; Roger Hurst, MD; Fabrizio Michelassi, MD; J. Michael Millis, MD; Mitchell C. Posner, MD

Arch Surg. 2000;135:530-534.

Hypothesis  The appropriate surgical treatment of patients with colorectal cancer who are found on initial presentation to have stage IV disease is controversial. With presumed limited life expectancy, the role of primary colon or rectal resection has been questioned, as has the utility of synchronous hepatic resection.

Design  A retrospective chart review.

Setting  The University of Chicago Hospitals, Chicago, Ill, a tertiary-care referral center.

Patients  One hundred twenty patients were identified through The University of Chicago Hospitals Tumor Registry whose initial presentation showed stage IV colorectal cancer and who underwent laparotomy.

Main Outcome Measures  The primary end points of the study were perioperative morbidity and mortality and overall survival.

Results  Median survival and 5-year survival were 14.4 months and 10%, respectively. Survival was greater for patients younger than 65 years than for those who were aged 65 years or older (18.3 vs 9.8 months; P=.007). Carcinomatosis was associated with significantly decreased survival when compared with less extensive stage IV disease (6.7 vs 18.1 months; P<.001). Patients who underwent any form of resection of hepatic metastases achieved a survival advantage over those with unresectable liver lesions (median survival, 29.6 vs 10.2 months; P<.001). Overall, 27 patients (22.5%) developed postoperative complications. Seven patients (5.8%) died during the postoperative period.

Conclusions  Age of 65 years or older, carcinomatosis, and extensive (bilobar) liver involvement are associated with decreased survival and increased postoperative morbidity and mortality and may negate any potential benefit patients derive from resection of the primary lesion. A substantial number of patients with synchronous hepatic metastases have protracted survival that justifies resection of the primary colorectal tumor at initial presentation. Despite the presence of stage IV disease, resection of the primary tumor and, when feasible, liver metastases is indicated.

From the Department of Surgery, The University of Chicago Hospitals, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(5):609-610.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease
Damjanov et al.
The Oncologist 2009;14:963-969.
ABSTRACT | FULL TEXT  

Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment
Poultsides et al.
JCO 2009;27:3379-3384.
ABSTRACT | FULL TEXT  

Colonoscopic Findings and Tumor Site Do Not Predict Bowel Obstruction During Medical Treatment of Stage IV Colorectal Cancer
Ballian et al.
The Oncologist 2009;14:580-585.
ABSTRACT | FULL TEXT  

Commentary: Colonoscopic Findings and Tumor Site Do Not Predict Bowel Obstruction During Medical Treatment of Stage IV Colon Cancer
Damjanov
The Oncologist 2009;14:578-579.
FULL TEXT  

Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases
Scheer et al.
Ann Oncol 2008;19:1829-1835.
ABSTRACT | FULL TEXT  

First-Line Chemotherapy vs Bowel Tumor Resection Plus Chemotherapy for Patients With Unresectable Synchronous Colorectal Hepatic Metastases
Galizia et al.
Arch Surg 2008;143:352-358.
ABSTRACT | FULL TEXT  

Stents for Palliation of Obstructive Metastatic Colon Cancer: Impact on Management and Chemotherapy Administration
Karoui et al.
Arch Surg 2007;142:619-623.
ABSTRACT | FULL TEXT  

Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at Diagnosis
Rapiti et al.
JCO 2006;24:2743-2749.
ABSTRACT | FULL TEXT  

Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential
Assikis et al.
Clin. Cancer Res. 2004;10:6770-6778.
ABSTRACT | FULL TEXT  

Use of Surgery Among Elderly Patients With Stage IV Colorectal Cancer
Temple et al.
JCO 2004;22:3475-3484.
ABSTRACT | FULL TEXT  

Carcinoembryonic Antigen and Albumin Predict Survival in Patients With Advanced Colon and Rectal Cancer
Dixon et al.
Arch Surg 2003;138:962-966.
ABSTRACT | FULL TEXT  

Liver Resection for Multiple Colorectal Metastases: Influence of Parenchymal Involvement and Total Tumor Volume, vs Number or Location, on Long-term Survival
Ercolani et al.
Arch Surg 2002;137:1187-1192.
ABSTRACT | FULL TEXT